Adiponectin, by activating the PI3K-AKT pathway, reduces IR, hyperandrogenemia, which not only regulates the metabolic system, but also promotes the proper functioning of the ovaries [20,114]. Here, AKT1 is linked to polycystic ovary syndrome.